Ignite Creation Date:
2025-12-24 @ 4:36 PM
Ignite Modification Date:
2026-01-04 @ 3:59 PM
Study NCT ID:
NCT06012266
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-02-07
First Post:
2023-08-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Repurposing Empagliflozin and Dapagliflozin for Paediatric Heart Failure: Translational Approach and Dose Rationale
Sponsor:
Centre Hospitalier Universitaire Vaudois
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-08
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-08
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-08
Completion Date Type:
ESTIMATED
First Submit Date:
2023-08-04
First Submit QC Date:
None
Study First Post Date:
2023-08-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-05
Last Update Post Date:
2024-02-07
Last Update Post Date Type:
ACTUAL